Sleep Health Education and Social Support Among Blacks With OSA

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT02628977
Collaborator
(none)
1,092
1
2
64
17.1

Study Details

Study Description

Brief Summary

The primary purpose of this study is to ascertain the effectiveness of tailored, peer based sleep health education and social support in increasing adherence rates to recommended Obstructive Sleep Apnea (OSA) evaluation and treatment among blacks at risk of Obstructive Sleep Apnea.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Peer Based Sleep Health Education and Social Support
  • Behavioral: Attention Control Group
N/A

Detailed Description

Obstructive sleep apnea (OSA), which disproportionately affects blacks (31% vs. 10%, whites), is a critical, preventable and/or treatable disease potentially causing increased cardiovascular disease (CVD) outcomes (e.g., obesity, diabetes, hypertension, stroke, arrhythmia, and chronic heart failure). Improving sleep may have direct effects in reducing CVD risk,2 enhancing brain functions, and increasing workplace productivity. Unfortunately, our focus groups suggest that most at-risk blacks are unaware of OSA symptoms or its related morbidity. Thus, it is imperative to address poor adherence among blacks with OSA, if we are to reduce health disparities associated with CVD outcomes between blacks and whites.

This is a randomized study with a total of 6 sites recruiting; 3 will serve as controls and 3 that will be intervention. Group A participants (Intervention group) will receive health education from a trained Peer Health Educator and Group B participants (Control group) will meet with a salon worker, barbershop worker, or church Health Ministry group leader. Participants will be asked to use a sleep diary and wear a home sleep test device to measure sleep for 7 days. They will be followed for 12 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
1092 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Tailored Peer-Based Sleep Health Education and Social Support Among Blacks With Obstructive Sleep Apnea
Study Start Date :
Nov 1, 2015
Actual Primary Completion Date :
Mar 1, 2021
Actual Study Completion Date :
Mar 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: OSA Health Education & Support Group

Participants randomly assigned to the intervention arm will receive OSA health education and social support from a trained Peer educator.

Behavioral: Peer Based Sleep Health Education and Social Support
Participants randomly assigned to the intervention arm will receive Obstructive Sleep Apnea education and social support from a trained Peer Educator.

Active Comparator: Attention Control Group

Participants in the attention control group will receive standard sleep literature, providing information about Obstructive Sleep Apnea and access to available sleep services.

Behavioral: Attention Control Group
Participants assigned to this arm of the study will receive standard sleep literature, providing information about OSA and access to available sleep services.

Outcome Measures

Primary Outcome Measures

  1. Rate of adherence to recommended home OSA evaluation and treatment after intervention exposure [12 Months]

    We will perform analysis on an intention-to-treat basis.

Secondary Outcome Measures

  1. Rate of Obstructive Sleep Apnea among black men and women at the community level [12 Months]

    Obstructive Sleep Apnea among minorities.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • self-reported race/ethnic minority

  • ages ≥18 years

  • accessible by telephone

  • consent to participate, which includes permission to release medical record information

  • A positive screening for OSA is necessary to be enrolled in the intervention protocol.

Exclusion Criteria:
  • are involved in another sleep study.

  • are unable to understand and sign this informed consent form.

  • know someone who is participating in this study.

  • had a heart attack or stroke within the past 12 weeks.

  • do not identify yourself as a racial/ethnic minority.

  • are pregnant.

  • Refuse to use the ARESTM home sleep test device.

  • Refuse to use the WatchPATTM home sleep test device.

  • are not at risk for sleep apnea.

Contacts and Locations

Locations

Site City State Country Postal Code
1 180 Madison Ave New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Girardin Jean Louis, MD, New York University Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT02628977
Other Study ID Numbers:
  • 14-01028
  • NCT02427815
First Posted:
Dec 11, 2015
Last Update Posted:
Jul 6, 2021
Last Verified:
Jul 1, 2021
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2021